COMPANY PRESENTATION

Enlitic (ASX:ENL) - Webinar Presentation
08 Nov 2024 - Michael Sistenich - CEO - Enlitic (ASX:ENL) is a healthcare technology company that uses AI to improve medical imaging analysis. Their platform enhances the detection and diagnosis of diseases by automatically interpreting images, helping radiologists make more accurate and efficient assessments.

PainChek (ASX:PCK) - Webinar Presentation
08 Nov 2024 - Philip Daffas - CEO & Managing Director - PainChek Limited (ASX:PCK) is a digital health company that offers a mobile app for pain assessment, using AI to analyse facial expressions and other indicators in patients unable to communicate verbally.

BPH Global (ASX:BP8) - Webinar Presentation
08 Nov 2024 - Paul Stephenson - Non-Executive Chairman - BPH Global Limited (ASX:BP8) is a diversified biotechnology company focused on the health and energy industries, with a primary focus on seaweed.

DXN (ASX:DXN) - Webinar Presentation
25 Oct 2024 - Shalini Lagrutta - Managing Director & CEO - DXN Limited (ASX:DXN) is redefining the way modern data centres are constructed and operated.

Sunstone Metals (ASX:STM) - Webinar Presentation
25 Oct 2024 - Patrick Duffy - Managing Director & CEO - Sunstone Metals Limited (ASX:STM) is an exploration company with two world-class gold and copper assets in Ecuador.

Australian Vintage (ASX:AVG) - Webinar Presentation
18 Oct 2024 - Craig Garvin - CEO - Australian Vintage Limited (ASX:AVG) is a leading Australian wine and drinks company whose brands are recognised and available in 40+ countries.

Askari Metals (ASX:AS2) - Webinar Presentation
18 Oct 2024 - Cliff Fitzhenry - Chief Exploration & Project Manager - Askari Metals Limited (ASX:AS2) is a battery metals-focused explorer and developer with a portfolio of exploration projects in Africa and Australia.

Neuren Pharmaceuticals (ASX:NEU) - Webinar Presentation
11 Oct 2024 - Jon Pilcher - Managing Director & CEO - Neuren Pharmaceuticals Limited (ASX:NEU) is developing new therapies for highly debilitating neurodevelopmental disorders that emerge in early childhood.

Alderan Resources (ASX:AL8) - Webinar Presentation
11 Oct 2024 - Scott Caithness - Managing Director - Alderan Resources Limited (ASX:AL8) is focused on copper and gold exploration in the US and lithium exploration in Brazil.

Mesoblast (ASX:MSB) - Webinar Presentation
04 Oct 2024 - Silviu Itescu - Managing Director & CEO - Mesoblast Limited (ASX:MSB) is developing innovative allogeneic cellular medicines to treat complex inflammatory diseases. The company’s portfolio of Phase 3 product candidates includes therapies for acute graft versus host disease, chronic heart failure and chronic low back pain.